Reprogramming Cell-Surface Protein Turnover for Autoimmune Disease

• Harnessing cell-surface E3 ligases to degrade pathogenic immune receptors
• Achieving potent, cell-selective target removal beyond conventional antibody blockade
• Sharing early mechanistic insights and considerations for degrader optimisation

Speakers:

Jase Brouwer

CSO and Co-founder

Proxima Bio